STOCK TITAN

Fennec Pharmaceuticals director proposes $240K sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Fennec Pharmaceuticals Inc. (FENC) director Marco Brughera, who signed as Marco Maria Brughera, gave notice of a proposed sale of 20,000 common shares, with an aggregate market value of $240,000.00 and an approximate sale date of November 13, 2026. The shares were acquired from the issuer on November 13, 2026 through a stock option exercise, with cash listed as the payment method. The notice reports 35,305,117 common shares outstanding and a September 15, 2026 sale of 15,545 common shares for gross proceeds of $160,069.97 during the prior three months. It lists June 16, 2026 as the plan adoption or instruction date, if relying on Rule 10b5-1.

Proposed sale 20,000 common shares Approximate sale date November 13, 2026
Aggregate market value $240,000.00 For the 20,000 common shares proposed for sale
Common shares outstanding 35,305,117 shares Reported in the securities information
Prior three-month sale 15,545 common shares Sold September 15, 2026
Gross proceeds $160,069.97 For the September 15, 2026 sale
Plan adoption or instruction date June 16, 2026 Listed if relying on Rule 10b5-1
Rule 10b5-1 regulatory
"if relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Aggregate Market Value financial
"Aggregate Market Value of 240000.00"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Stock Option Exercise financial
"Nature of Acquisition Transaction: Stock Option Exercise"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FENC shares did Marco Brughera propose to sell, and for what value?

Marco Brughera reported a proposed sale of 20,000 common shares with an aggregate market value of $240,000.00. The approximate sale date listed is November 13, 2026.

What FENC shares did Marco Brughera sell during the prior three months?

The notice lists a sale of 15,545 common shares on September 15, 2026, for gross proceeds of $160,069.97.

Which broker and exchange are listed for Marco Brughera's proposed FENC sale?

The listed broker is Morgan Stanley Smith Barney LLC, and the exchange named is NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading